Search results
Added:
3 years ago
Can screening patients routinely for atrial fibrillation (AF) before it is diagnosed, help to prevent stroke occurrence by prescribing anticoagulation to those with discovered AF?
Dr Steven Lubitz (Massachusetts General Hospital, Boston, MA, US) discusses the results of the VITAL-AF trial which assessed the effectiveness of screening for undiagnosed atrial fibrillation (AF) using simple,…
View more
Author(s):
Anna E Platek
,
Anna Hrynkiewicz-Szymanska
,
Karolina Semczuk
,
et al
Added:
3 years ago
Young Investigator Award
Topic: 4. Arrhythmias
Introduction and Objectives
Guidelines of the European Society of Cardiology (ESC) from 2016 recommend pre-treatment with non- antiarrhythmic drugs (namely ACE-Is or ARBs) in patients with recurrent atrial fibrillation (AF), in whom rhythm control strategy is considered.1 This recommendation is based on possible antiarrhythmic effects of these…
View more
Harry Crijns
Research Area(s) / Expertise:
Author
Keitaro Senoo
Research Area(s) / Expertise:
Job title: Kyoto Prefectural University of Medicine, Kyoto, JP
Author
Author(s):
Jonathan Piccini
Added:
1 year ago
AHA 22 - Dr Jonathan Piccini(Duke University Medical Center, Durham, US) joins us to discuss the findings of the NOVA Phase II trial (NCT03779841).
NOVA Phase II is a multicenter, randomized, dose-ranging study that aims to find the efficacy and safety of botulinum toxin type A (AGN-151607) (AbbVie)in preventing post-operative atrial fibrillation (POAF) in patients undergoing open-chest cardiac…
View more
Jeroen Hendriks
Research Area(s) / Expertise:
Job title: Professor of Cardiovascular Nursing, MSc
Author
John M Miller
Research Area(s) / Expertise:
Author
Eue-Keun Choi
Research Area(s) / Expertise:
Job title: Professor
Author
Added:
11 months ago
EHRA 2023 — Investigator, Prof Nicolas Doll (Schuechtermann-Klinik, DE) joins us to discuss the take-home messages from the international prospective randomised multi-centre CEASE-AF study (NCT02695277).
In a randomized controlled trial, 146 patients were enrolled to compare the safety, efficacy, and quality of life outcomes of a combined epicardial surgical plus endocardial catheter technique…
View more
Author(s):
Naima Maqsood
,
Jeff Healey
Added:
4 months ago
AHA 2023 — Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews investigator, Dr Jeff Healey (McMaster University, CA) to outline the findings from a phase 4 trial of apixaban to reduce thromboembolism in patients with subclinical atrial fibrillation (AF).ARTESiA (NCT01938248) aims to determine if apixaban in combination with aspirin can reduce the instance of…
View more